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1. SUPPLEMENTARY FIGURES 
 54 
Figure E1. Concurrent S. aureus Colonization and Eczema Severity 
 55 
The percent of individuals with SCORAD assessments for eczema of 0, >0-15, ≥15-40 and >40 are shown at 4-11, 12, 30, and 60 months within those who do not 56 
have concurrent S. aureus (left bar of each pair) and those who do have concurrent S. aureus (right bar of each pair) in the intention to treat population.  Skin S. 57 
aureus colonization is shown in the left panel while Nasal S. aureus colonization is shown in the right panel.   58 
  
S. aureus and food allergy in LEAP/LEAP-On  Tsilochristou et al. 4 
Figure E2. Eczema Severity by Nasal S. aureus Colonization at the Preceding Visit 
 59 
Data is presented for all participants who were in LEAP and LEAP-On with available SCORAD data for each study assessment time point divided into groups based 60 
on whether the subjects had nasal S. aureus at the previous visit (in red) or did not have nasal S. aureus at the previous visit (in blue).  Black diamonds represent 61 
model predicted means, boxes represent 25th and 75th centiles, error bars represent 2.5th and 97.5th centiles, and the middle line of each box represents the 62 
median.  The total number of subjects contributing to the analysis at each time point, p-values, mean differences and 95% confidence intervals around that mean 63 
difference directly above each assessment time point refer to the least squares mean difference (S. aureus – no S. aureus) and p-value comparison between those 64 
who had nasal S. aureus at the previous visit and those who did not have nasal S. aureus at the previous visit using a longitudinal model adjusted for SCORAD at 65 
the previous visit, time, S. aureus status at the previous visit, and the interaction between S. aureus status at the previous visit and time.  66 
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Figure E3. Hen’s Egg White sIgE Over Time by Skin S. aureus Colonization Status 
 67 
Data is presented for all participants who were in LEAP and LEAP-On with available Hen’s Egg White Specific IgE data for each study assessment time point divided 68 
into groups based on whether subjects ever had skin S. aureus from baseline (4-11 mo) to 60 months (in red) or never had skin S. aureus from baseline (4-11 mo) 69 
to 60 months (in blue).  Black diamonds represent model predicted means, boxes represent 25th and 75th centiles, error bars represent 2.5th and 97.5th centiles, 70 
and the middle line of each box represents the median.  The total number of subjects contributing to the analysis at each time point, p-values, mean differences 71 
and 95% confidence intervals around that mean difference directly above each assessment time point refer to the comparison between those who never have S. 72 
aureus and those who ever have S. aureus using a longitudinal repeated measures model adjusted for SCORAD, time, S. aureus status, and the interaction between 73 
S. aureus status and time.  Average SCORAD values at each time point are annotated directly below the box plots for those who ever had skin S. aureus (red) and 74 
those who never had skin S. aureus (blue). 75 
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Figure E4. Relative Distribution of Cow’s Milk sIgE and Total IgE Over Time by Skin S. aureus Colonization 
 76 
 77 
These figures show the relative distribution of milk-specific IgE and Total IgE between those who ever have skin S. aureus (shown in red) from 4-11 months to 60 78 
months and those who never have skin S. aureus (shown in blue).  The vertical reference lines indicate where the distribution begins to significantly differ (p < 79 
0.05) between the two groups using bootstrap sampling of 1000 replicates of the upper percentiles indicating that those with S. aureus colonization are over 80 
represented in the higher end of the distribution of IgE. A reference panel is included to illustrate the 67.8% of the trial participants who never had skin S. aureus 81 
and the 32.2% who ever had skin S. aureus and what a pattern with no association of skin S. aureus with IgE levels would look like.  82 
 83 
  84 
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Figure E5. Correlation Between Total IgE and Food Specific IgEs 
 85 
 86 
Data is presented for all participants who were in LEAP and LEAP-On with available Milk sIgE, Egg sIgE, Peanut sIgE, and Total IgE.  Data at all available time 87 
points are included in each panel.  Linear regression lines and 95% confidence intervals between Total IgE and food specific IgEs are displayed for each 88 
assessment time 4-11 (in blue), 30 (in red), 60 (in green), and 72 months (in brown).  Total IgE was not collected at 12 months; therefore the 12 months data is 89 
not reported here.  Pearson correlations between Total IgE and food specific IgEs averaged over all time points are displayed in each panel.  90 
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Figure E6. Forest Plot of Skin S. aureus Colonization with Food Specific IgE and Total IgE 
 91 
 92 
This forest plot shows odds ratios and 95% confidence intervals from 3 multivariate logistic regression models.  The outcome of each model is skin S. aureus 93 
colonization at any time point and the predictors are Total IgE and each food specific IgE at 60 months individually in each model.  The odds ratios for a 1 log unit 94 
change in each predictor are plotted showing a positive association with food specific IgE and skin S. aureus.  95 
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Figure E7. Peanut Allergy in Relation to Nasal S. aureus Colonization and Treatment Assignment 
 96 
 97 
 98 
Percentages (from raw data), odds ratios, and 95% confidence intervals from multiple multivariate logistic regression models using the Firth penalized likelihood 99 
method are displayed.  One model was fit for the 60 month data (outcome of interest being peanut allergy as assessed by oral food challenge at 60 months), and 100 
another model was fit for the 72 month data (outcome of interest being peanut allergy as assessed by oral food challenge at 72 months).  Predictors of interest 101 
included nasal S. aureus colonization status adjusted for SCORAD (at 60 and 72 months respectively), LEAP treatment assignment, and the interaction between 102 
nasal S. aureus status and treatment assignment.  Panel A of the plot summarizes the relationship between peanut allergy and nasal S. aureus colonization status 103 
(overall, within consumers, and within avoiders).  In the ‘Percent’ panel, the numerators refer to the number of subjects with peanut allergy while the denominators 104 
refer to the number of subjects with nasal S. aureus (in red) and those without nasal S. aureus (blue).  Panel B of the plot summarizes the relationship between 105 
peanut allergy and peanut consumption (overall, within those with nasal S. aureus, within those without nasal S. aureus). In the ‘Percent’ panel, the numerators 106 
refer to the number of subjects with peanut allergy while the denominators refer to the number of subjects in the avoidance group (in grey) and those in the 107 
consumption group (green). Interpret results with caution as a small number of subjects with peanut allergy (especially in the Peanut Consumption arm) contribute 108 
to these analyses. 109 
  110 
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Figure E8. Peanut Allergy in Relation to Skin and/or Nasal S. aureus Colonization and Treatment Assignment 
 111 
 112 
 113 
Percentages (from raw data), odds ratios, and 95% confidence intervals from multiple multivariate logistic regression models using the Firth penalized likelihood 114 
method are displayed.  One model was fit for the 60 month data (outcome of interest being peanut allergy as assessed by oral food challenge at 60 months), and 115 
another model was fit for the 72 month data (outcome of interest being peanut allergy as assessed by oral food challenge at 72 months).  Predictors of interest 116 
included skin and/or nasal S. aureus colonization status adjusted for SCORAD (at 60 and 72 months respectively), LEAP treatment assignment, and the interaction 117 
between skin and/or nasal S. aureus status and treatment assignment.  Panel A of the plot summarizes the relationship between peanut allergy and skin and/or 118 
nasal S. aureus colonization status (overall, within consumers, and within avoiders).  In the ‘Percent’ panel, the numerators refer to the number of subjects with 119 
peanut allergy while the denominators refer to the number of subjects with skin and/or nasal S. aureus (in red) and those without skin and/or nasal S. aureus 120 
(blue).  Panel B of the plot summarizes the relationship between peanut allergy and peanut consumption (overall, within those with skin and/or nasal S. aureus, 121 
within those without skin and/or nasal S. aureus). In the ‘Percent’ panel, the numerators refer to the number of subjects with peanut allergy while the 122 
denominators refer to the number of subjects in the avoidance group (in grey) and those in the consumption group (green). Interpret results with caution as a 123 
small number of subjects with peanut allergy (especially in the Peanut Consumption arm) contribute to these analyses.   124 
  125 
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Figure E9. Timeline of Peanut Consumption, Peanut Allergy, Nasal S. aureus and Skin S. aureus Colonization for Subjects 
Who Became Allergic in the LEAP Consumption Group  
 126 
The 9 (6 by 60 months and an additional 3 by 72 months) LEAP Consumers who became allergic are displayed. This timeline illustrates the length of time each 127 
subject consumed peanut (in green), when they tested positive for nasal S. aureus (red box), when they tested positive for skin S. aureus (red circle), and diagnosis 128 
of peanut allergy at the end of LEAP and/or LEAP-On (black asterisk). Subjects 001 to 003 had a negative peanut challenge at 60 months but a positive one at 72 129 
months. Subjects 004 to 009 stopped peanut consumption due to allergic reactions following peanut consumption as opposed to subjects 001 to 003 who 130 
consumed peanut until 60 months as per the LEAP protocol. All the subjects in this plot, aside from Subject 002, had skin and/or nasal S. aureus at some point 131 
during LEAP (4-11 to 60 months of age).  132 
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2. SUPPLEMENTARY TABLES 
 133 
Table E1. Prevalence and Persistence of Skin and Nasal S. aureus Colonization by LEAP Treatment Groups 
 134 
 S. aureus Skin Swab Results 
 
 S. aureus Nasal Swab Results  S. aureus Skin or Nasal Swab Results 
  Peanut 
Avoidance 
Peanut 
Consumption 
 
p-value 
  Peanut 
Avoidance 
Peanut 
Consumption 
 
p-value 
  Peanut 
Avoidance  
Peanut 
Consumption  
 
p-value 
                        
4-11 (mo)      0.690        0.204        0.530 
    N 321 319     321 319     321 319   
    No S. aureus 260 (81.0%) 265 (83.1%)     278 (86.6%) 266 (83.4%)     240 (74.8%) 234 (73.4%)   
    S. aureus 61 (19.0%) 54 (16.9%)     43 (13.4%) 53 (16.6%)     81 (25.2%) 85 (26.6%)   
                        
12 (mo)      0.507        0.357        0.856 
    N 315 311     315 311     315 311   
    No S. aureus 281 (89.2%) 282 (90.7%)     300 (95.2%) 291 (93.6%)     272 (86.3%) 267 (85.9%)   
    S. aureus 34 (10.8%) 29 (9.3%)     15 (4.8%) 20 (6.4%)     43 (13.7%) 44 (14.1%)   
                        
30 (mo)      0.803        0.249        0.640 
    N 310 308     310 308     310 308   
    No S. aureus 290 (93.5%) 288 (93.5%)     291 (93.9%) 295 (95.8%)     276 (89.0%) 276 (89.6%)   
    S. aureus 20 (6.5%) 20 (6.5%)     19 (6.1%) 13 (4.2%)     34 (11.0%) 32 (10.4%)   
                        
60 (mo)      0.827        0.526        0.676 
    N 316 314     316 314     316 314   
    No S. aureus 292 (92.4%) 293 (93.3%)     271 (85.8%) 265 (84.4%)     254 (80.4%) 251 (79.9%)   
    S. aureus 24 (7.6%) 21 (6.7%)     45 (14.2%) 49 (15.6%)     62 (19.6%) 63 (20.1%)   
                        
Ever Colonized (4-11 mo to 60 mo)     0.650       0.976       0.478 
    N 321 319     321 319     321 319   
    No S. aureus 215 (67.0%) 219 (68.7%)     217 (67.6%) 216 (67.7%)     169 (52.6%) 159 (49.8%)   
    S. aureus 106 (33.0%) 100 (31.3%)     104 (32.4%) 103 (32.3%)     152 (47.4%) 160 (50.2%)   
                        
Number of Visits     0.409       0.395       0.801 
    N 321 319     321 319     321 319   
    0 215 (67.0%) 219 (68.7%)     217 (67.6%) 216 (67.7%)     169 (52.6%) 159 (49.8%)   
    1 82 (25.5%) 79 (24.8%)     87 (27.1%) 74 (23.2%)     101 (31.5%) 106 (33.2%)   
    2 16 (5.0%) 18 (5.6%)     16 (5.0%) 27 (8.5%)     35 (10.9%) 45 (14.1%)   
    3 7 (2.2%) 3 (0.9%)     1 (0.3%) 1 (0.3%)     15 (4.7%) 8 (2.5%)   
    4 1 (0.3%) 0 (0.0%)     0 (0.0%) 1 (0.3%)     1 (0.3%) 1 (0.3%)   
 135 
Note: P-values for Number of Visits are based on Cochran-Armitage trend tests. P-values for Ever Colonized are based on Chi-Squared tests.  All other p-values 136 
are based on three separate longitudinal models (skin, nasal, and the combination of skin or nasal S. aureus) with the outcome of interest being S. aureus 137 
colonization status adjusted for LEAP treatment assignement, SCORAD, time, and the interaction between LEAP treatment assignment and time. 138 
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Table E2. Agreement Between Skin and Nasal S. aureus Colonization Over Time 
 139 
 4-11 (mo) 
Nasal S. aureus 
  12 (mo) 
Nasal S. aureus 
  30 (mo) 
Nasal S. aureus 
  60 (mo) 
Nasal S. aureus 
  Ever Colonized (4-11 mo to 60 mo) 
Nasal S. aureus 
                    
 
 
 
 
No  
S. aureus 
(N=544) 
 
 
S. aureus 
(N=96) 
     
 
 
 
No  
S. aureus 
(N=591) 
 
 
S. aureus 
(N=35) 
     
 
 
 
No  
S. aureus 
(N=586) 
 
 
S. aureus 
(N=32) 
     
 
 
 
No  
S. aureus 
(N=536) 
 
 
S. aureus 
(N=94) 
     
 
 
 
No  
S. aureus 
(N=433) 
 
 
S. aureus 
(N=207) 
    
       
Statistic 
95% CI 
 
 
p-value 
       
Statistic 
95% CI 
 
 
p-value 
       
Statistic 
95% CI 
 
 
p-value 
       
Statistic 
95% CI 
 
 
p-value 
       
Statistic 
95% CI 
 
 
p-value 
                                                  
                                                  
Skin S. aureus         0.31 <0.001           0.16 <0.001           0.12  0.004           0.12  0.002           0.25 <0.001 
 No S. aureus 474 (87.1%) 51 (53.1%) (0.22, 0.41)     539 (91.2%) 24 (68.6%) (0.05, 0.28)     552 (94.2%) 26 (81.3%) (0.00, 0.24)     505 (94.2%) 80 (85.1%) (0.02, 0.21)     328 (75.8%) 106 (51.2%) (0.17, 0.32)   
 S. aureus 70 (12.9%) 45 (46.9%)       52 (8.8%) 11 (31.4%)       34 (5.8%) 6 (18.8%)       31 (5.8%) 14 (14.9%)       105 (24.2%) 101 (48.8%)     
 140 
Note: P-values are based on Kappa Statistics.  The Kappa Statistics ranges from 0-1 (1 indicating perfect agreement and 0 indicating no agreement). 141 
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3. SUPPLEMENTARY TO THE TEXT 
Severe eczema was an inclusion criterion for LEAP enrolment; indeed 89.2% of children had protocol defined severe 142 
eczema at recruitment (1). Overall, approximately half of all LEAP participants had some form of S. aureus colonization in 143 
the interval from baseline to 60 months of age (Table 1) and usually at only one of the four time points (Online Repository 144 
Table E1). The highest rates of colonization were recorded at the baseline visit, with 18% and 15% for the skin and nose 145 
respectively. That these colonization rates are lower than previously reported in patients with eczema (2), may be because 146 
swabs were only collected at 4 study time points which did not necessarily coincide with occasions when eczema might 147 
have been flaring, while S. aureus colonization is known to be transient. With the exception of the results at 60 months of 148 
age, the skin was more commonly the sole colonized location compared to the nose while concomitant nasal and skin 149 
colonization was the least common colonization pattern observed. Nasal carriage has been acknowledged as a risk factor 150 
for skin S. aureus re-colonization (3) and our findings of relatively low nasal colonization rates in the LEAP cohort may thus 151 
explain why the majority of participants only tested positive on one occasion. Notably and reassuringly, there was a low 152 
prevalence of methicillin-resistant S. aureus skin and nasal swab samples which also explains the non-persistent 153 
colonization pattern of the LEAP subjects. Despite the low concomitant skin and nasal colonization rates, our results do 154 
indicate a weak association between this concomitant S. aureus carriage at all study time points.  155 
Meanwhile, although antibiotic treatment usually reduces S. aureus colonization and steroids or combined 156 
steroid/antibiotic formulations (4) appear to have a similar result, we found no difference in baseline skin S. aureus 157 
colonization amongst the subjects that were reported at baseline to have received these medications versus those that 158 
did not. Consequently, we did not proceed with an investigation of the relationship between S. aureus colonization and 159 
antibiotic/steroid use at later LEAP study visits.   160 
The association between skin S. aureus and concomitant eczema severity was highly significant at all LEAP time points as 161 
opposed to that with nasal S. aureus whichwas  weaker . The association between skin S. aureus and eczema severity is 162 
consistent with the report of a recent systematic review (2) which was unable to identify an association between nasal 163 
carriage and eczema severity. As LEAP participants with skin S. aureus had more severe eczema, we sought to investigate 164 
the causality of this relationship through a longitudinal model examining the correlation between immediately preceding 165 
skin S. aureus positivity and eczema severity. Interestingly, we found that the immediately preceding skin S. aureus 166 
colonization altered the pattern of eczema resolution observed from 12 to 30 months and 60 to 72 months of age. In 167 
particular, subjects found to be skin colonized at 12 months of age, and similarly at 60 months of age, were represented 168 
in Figure 1 with increasing disease trajectories due to higher mean SCORAD values at the subsequent follow-up visits. This 169 
was not the case for the participants without skin S. aureus carriage, reflected also by the fact that overall eczema severity 170 
was consistently reduced throughout LEAP and LEAP-On. Literature reports that S. aureus and/or SEB may cause, 171 
exacerbate and sustain the inflammatory process in eczema and can thus support our results (2,5, 6). Finally, according to 172 
the latent eczema classes recently described on the basis of two birth cohorts by Paternoster et al, the most prevalent 173 
class is the early-onset-early-resolving eczema phenotype characterized by a decline to 10% of eczema (defined as the 174 
reported presence of a rash consistent with eczema) prevalence by 6-7 years (7). Further to this, in our study skin S. aureus 175 
could predict the subsequent change of the early-onset-early-resolution eczema phenotype to a more persistent and 176 
worsening phenotype.  177 
  178 
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